Spirometry Interpretation in Asthma Patients

Key Spirometric Parameters and Interpretation

The European Respiratory Society recommends spirometry in all patients aged 5-16 years with suspected asthma, focusing on airflow obstruction patterns and bronchodilator reversibility 1, 2
FEV1 (Forced Expiratory Volume in 1 second) represents the volume of air expired in the first second of forced expiration, and is a key parameter in asthma diagnosis 2
FVC (Forced Vital Capacity) is the total volume of air expired from start to end of forced expiration maneuver, and is used in conjunction with FEV1 to diagnose asthma 2
The FEV1/FVC ratio is a key indicator of airflow obstruction when reduced, and is used to support an asthma diagnosis 2
Bronchodilator response (BDR) is the change in lung function following bronchodilator administration, and an increase in FEV1 ≥ 12% and/or ≥ 200 mL is diagnostic of asthma 3, 4

Diagnostic Criteria and Testing

The European Respiratory Society recommends assessing baseline spirometry, including FEV1 and FEV1/FVC ratio, to support an asthma diagnosis 2, 3
A negative bronchodilator response (< 12%) does not exclude asthma, and further testing such as peak expiratory flow rate (PEFR) variability or bronchial challenge testing may be necessary 3
PEFR variability testing may be used to support an asthma diagnosis, with variability > 10% in adults and > 13% in children suggesting asthma 1, 5
Bronchial challenge testing, such as methacholine or exercise challenge, may be used to support an asthma diagnosis, with a PC20 < 8 mg/mL in methacholine challenge or a fall in FEV1 > 10% in exercise challenge suggesting asthma 1, 6

Important Considerations

One-time spirometry has low sensitivity (0.12-0.52) but moderate to high specificity (0.72-0.93) for asthma diagnosis, and serial measurements may be required due to the variable nature of asthma 2
Proper technique is critical, and poor effort can lead to false results 5
Fixed FEV1/FVC ratio cutoffs may lead to false positives in older adults and false negatives in younger adults, and should be used with caution 7
Exhaled nitric oxide (FeNO) testing may be used to complement spirometry, with FeNO ≥ 25 ppb supporting an asthma diagnosis when spirometry is normal 1

Asthma Diagnosis with Normal Spirometry

Introduction to Asthma Diagnosis

The European Respiratory Society guidelines state that normal spirometry does not exclude asthma, and this principle applies to both children and adults 8
Asthma is a variable condition, and when well-controlled or between symptomatic episodes, spirometry is frequently normal, as noted by the European Respiratory Society and Thorax 9, 10

Diagnostic Approaches

The European Respiratory Society recommends measuring FeNO (Fractional Exhaled Nitric Oxide) after normal spirometry, with a value ≥25 ppb supporting the diagnosis of asthma 8
Bronchodilator reversibility testing should be considered even with normal baseline spirometry if clinical suspicion is strong, according to the European Respiratory Society 11, 10
Peak expiratory flow rate (PEFR) variability testing, with variability ≥12% over 2 weeks, suggests asthma and is particularly practical when repeated spirometry is not feasible, as recommended by the European Respiratory Society and Thorax 8, 9

Diagnostic Criteria

The European Respiratory Society recommends diagnosing asthma only when at least two objective test results are abnormal, as no single test is sufficient by itself 8
Serial spirometry measurements may be required to capture the variable airflow obstruction, particularly if testing is performed when the patient is asymptomatic, as noted by the European Respiratory Society 11, 10

Testing and Diagnosis

Bronchial challenge testing (methacholine or exercise challenge) should be performed when asthma diagnosis cannot be confirmed with other objective tests, with a PC₂₀ <8 mg/mL on methacholine challenge being diagnostic, according to the European Respiratory Society 8
Any positive change in FEV₁ post-bronchodilator (even if <12%) can be a predictor of asthma, as noted by the European Respiratory Society 11

Essential Spirometric Criteria for Asthma Diagnosis

Core Diagnostic Parameters

The European Respiratory Society (ERS) states that asthma diagnosis must be based on a reduced FEV₁/FVC ratio (below the lower limit of normal or < 80 %), which signifies airway obstruction, rather than on isolated FVC values. 12
In addition to the ratio, the ERS recommends that a FEV₁ below the lower limit of normal or < 80 % of predicted provides supportive evidence for asthma. 13

Baseline Spirometry Procedure

Baseline spirometry should record FEV₁, FVC, and calculate the FEV₁/FVC ratio; the ERS advises using the lower limit of normal (LLN) rather than fixed cut‑offs whenever feasible. 14
Inadequate technique during the FVC maneuver can falsely normalize the FEV₁/FVC ratio, potentially leading to missed asthma diagnoses. 15

Bronchodilator Testing

After administration of a short‑acting β₂‑agonist, the ERS recommends re‑measuring FEV₁ (not FVC) after 15 minutes to assess reversibility. 16

Additional Objective Tests (When Baseline Spirometry Is Normal)

Peak expiratory flow variability greater than 10 % in adults or 13 % in children supports an asthma diagnosis. 16
Methacholine challenge testing showing a PC₂₀ < 8 mg/mL indicates airway hyper‑responsiveness consistent with asthma. 17

Common Diagnostic Pitfalls (Guidance from the ERS)

Do not diagnose asthma solely on symptom improvement after a therapeutic trial; objective testing is required. 13
Isolated changes in FVC without evaluation of the FEV₁/FVC ratio are insufficient for diagnosing asthma. 12
A single normal spirometry result does not rule out asthma; because the disease is variable, serial testing may be necessary. 14
Normal spirometry does not exclude asthma, as patients may have normal values when well‑controlled or between exacerbations. 12

Asthma Misdiagnosis and the Likelihood of True Resolution in Adults

Prevalence of Misdiagnosis

Up to 45 % of patients who report having asthma are actually over‑diagnosed when they are later evaluated with objective measures such as spirometry and bronchodilator testing. This reflects a substantial rate of false‑positive diagnoses. 18
Misdiagnosis rates are especially high when the diagnosis relies solely on clinical history without objective testing, underscoring the need for spirometry, bronchodilator response, or airway‑challenge studies at the time of initial evaluation. [19][18]
A large proportion of individuals labeled as asthmatic never underwent spirometry or bronchodilator testing at the time of their original diagnosis, leaving the initial classification unverified. 18

Natural History of Adult‑Onset Asthma

Adult‑onset asthma (diagnosed in the fifth decade of life) rarely resolves spontaneously and is associated with a faster decline in lung function compared with asthma that begins in childhood. 20

Diagnostic Testing Value

Methacholine (or other bronchial challenge) testing has a high negative predictive value; a negative challenge makes the presence of asthma very unlikely. The diagnostic threshold is a PC₂₀ < 8 mg/mL for a positive result. 21
When a supervised step‑down of inhaled corticosteroid/long‑acting β‑agonist therapy is considered, close follow‑up (e.g., every 4–6 weeks with symptom review and spirometry) is recommended to detect early loss of control. This approach is supported by evidence on safe medication reduction in confirmed asthma. 21

Overall Likelihood in the Presented Scenario

Considering the high rates of asthma misdiagnosis when objective testing is omitted and the rarity of spontaneous resolution in adult‑onset disease, the most plausible explanation for a patient with normal spirometry while on controller therapy is that she never truly had asthma. Definitive determination, however, requires additional objective testing. [18][20]